The perioperative environment is increasingly shaped by factors that extend beyond traditional pharmacology, requiring anesthesia providers to stay alert to emerging and often underrecognized influences on patient care. One such factor is the growing use of kratom, a plant-derived substance that patients frequently perceive as harmless due to its “natural” origins. However, as highlighted in today’s show, this assumption can lead to critical gaps in disclosure, leaving clinicians unaware of a substance that may significantly alter anesthetic management and patient outcomes. Here’s some of what you’ll hear in this episode: 🌿 Kratom acts as both a stimulant and opioid-like substance ⚠️ “Natural” does not mean safe or predictable 🧪 Potency and composition vary widely between products 😴 Patients may present with opioid tolerance or sedation 😵 Withdrawal can mimic pain, agitation, or delirium Visit us online: https://beyondthemaskpodcast.com/ The 1099 CRNA Institute: https://aana.com/1099 Get the CE Certificate here (and directly submit to the NBCRNA): https://beyondthemaskpodcast.com/wp-content/uploads/2020/04/Beyond-the-Mask-CE-Cert-FILLABLE.pdf Help us grow by leaving a review: https://podcasts.apple.com/us/podcast/beyond-the-mask-innovation-opportunities-for-crnas/id1440309246 Now you can watch the show on YouTube! Check it out here: https://www.youtube.com/channel/UCknrmkRxiwtYk7LUjSV6wmw?sub_confirmation=1

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related